Physician

Sk MD Hameem I Kawsar, MD., PH.D.

According to 2025 Medicare claims, Sk Kawsar, MD., PH.D. (NPI: 1033430798) practices hematology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (NPI: 1215989249; TIN: 223376459) and primary practice location at 08050-2414. Kawsar is affiliated with the eBrightHealth ACO (ACO ID: A3053), participating under the MSSP model.

Kawsar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 208 traditional Medicare patients, billed 527 HCPCS/CPT codes, and received $44,892 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 255 prescription claims across 69 beneficiaries totaling $524,970 in drug costs, led by Creon (Lipase/Protease/Amylase). 2022 DME data shows 48 claims. Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $33,023 to $44,892. Similarly, Part D prescription costs have moved sharply higher in recent years, from $129,924 to $524,970. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $988 to $3,235.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	334	501	$33,023
2016	222	407	$28,067
2017	203	272	$19,966
2018	263	286	$26,623
2019	213	334	$29,312
2020	155	180	$19,304
2021	83	1,349	$40,654
2022	164	549	$49,989
2023	118	953	$46,557
2024	208	527	$44,892

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	286	2,651	$129,924
2016	295	2,614	$153,592
2017	260	2,529	$183,219
2018	282	2,207	$177,136
2019	73	174	$12,273
2020	N/R	35	$1,165
2021	14	27	$1,567
2022	58	222	$77,724
2023	55	317	$605,483
2024	69	255	$524,970

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	50	$571
2016	37	54	$274
2017	13	42	$388
2018	13	33	$560
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	48	$3,493
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	39	39	$185
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	21	23	$142
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	52	85	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	33	71	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	97	172	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	15	450	$4,613
Hydroxyurea	Hydroxyurea	15	1,025	$939
Albuterol Sulfate Hfa	Albuterol Sulfate	12	192	$392
Prochlorperazine Maleate	Prochlorperazine Maleate	18	134	$201
Ondansetron Hcl	Ondansetron Hcl	16	157	$148

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$17	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sk MD Hameem I. Kawsar, MD., PH.D.?

Tedicare shows public-source Medicare data for Sk MD Hameem I. Kawsar, MD., PH.D. (NPI 1033430798), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sk MD Hameem I. Kawsar, MD., PH.D. have ACO affiliation data?

Sk MD Hameem I. Kawsar, MD., PH.D. is shown with ACO affiliation data for eBrightHealth ACO (MSSP, ACO ID A3053).

What billing organization is linked to Sk MD Hameem I. Kawsar, MD., PH.D.?

Sk MD Hameem I. Kawsar, MD., PH.D. is linked to HACKENSACK MERIDIAN HEALTH MEDICAL GROUP - SPECIALTY CARE PC (billing NPI 1215989249) in the available physician profile data.

Does Sk MD Hameem I. Kawsar, MD., PH.D. have Open Payments data?

Sk MD Hameem I. Kawsar, MD., PH.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.